ATP and adenosine—Two players in the control of seizures and epilepsy development

Adami, 1995, “Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.”, Eur. J. Pharmacol., 294, 383, 10.1016/0014-2999(95)00557-9 Adinolfi, 2018, “The P2X7 receptor: a main player in inflammation.”, Biochem. Pharmacol., 151, 234, 10.1016/j.bcp.2017.12.021 Alves, 2017, “Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.”, Epilepsia, 58, 1603, 10.1111/epi.13850 Alves, 2018, “The metabotropic purinergic P2Y receptor family as novel drug target in epilepsy.”, Front. Pharmacol., 9, 193, 10.3389/fphar.2018.00193 Alves, 2019, “Context-Specific switch from Anti- to pro-epileptogenic function of the P2Y1 receptor in experimental epilepsy.”, J. Neurosci., 39, 5377, 10.1523/JNEUROSCI.0089-19.2019 Alves, 2019, “Differential expression of the metabotropic P2Y receptor family in the cortex following status epilepticus and neuroprotection via P2Y1 antagonism in mice.”, Front. Pharmacol., 10, 1558, 10.3389/fphar.2019.01558 Amhaoul, 2016, "P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy.", Neuropharmacology, 105, 175, 10.1016/j.neuropharm.2016.01.018 Amorim, 2016, “Effects of A1 receptor agonist/antagonist on spontaneous seizures in pilocarpine-induced epileptic rats.”, Epilepsy Behav., 61, 168, 10.1016/j.yebeh.2016.05.036 Amorim, 2017, “Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.”, Purinergic Signal., 13, 467, 10.1007/s11302-017-9573-4 Armstrong, 2002, “Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase.”, J. Neurosci., 22, 5938, 10.1523/JNEUROSCI.22-14-05938.2002 Aronica, 2011, "Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.", Epilepsia, 52, 1645, 10.1111/j.1528-1167.2011.03115.x Aronica, 2013, “Glial adenosine kinase--a neuropathological marker of the epileptic brain.”, Neurochem. Int., 63, 688, 10.1016/j.neuint.2013.01.028 Augusto, 2013, “Ecto-5’-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions.”, J. Neurosci., 33, 11390, 10.1523/JNEUROSCI.5817-12.2013 Avignone, 2008, “Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling.”, J. Neurosci., 28, 9133, 10.1523/JNEUROSCI.1820-08.2008 Avignone, 2015, “Altered morphological dynamics of activated microglia after induction of status epilepticus.”, J. Neuroinflammation, 12, 202, 10.1186/s12974-015-0421-6 Aymerich, 2005, “The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?”, Biochem. Soc. Trans., 33, 216, 10.1042/BST0330216 B.B. Fredholm, 1999, “Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.”, Pharmacol. Rev., 51, 83 Baldwin, 2004, “The equilibrative nucleoside transporter family, SLC29.”, Pflugers Arch., 447, 735, 10.1007/s00424-003-1103-2 Baldwin, 2005, “Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.”, J. Biol. Chem., 280, 15880, 10.1074/jbc.M414337200 Barnes, 2006, “Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.”, Circ. Res., 99, 510, 10.1161/01.RES.0000238359.18495.42 Barraco, 1990, “Pharmacological evidence for the modulation of monoamine release by adenosine in the invertebrate nervous system.”, J. Neurochem., 54, 2002, 10.1111/j.1471-4159.1990.tb04904.x Barros-Barbosa, 2016, “Adenosine A2A receptor and ecto-5’-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE).”, Purinergic Signal., 12, 719, 10.1007/s11302-016-9535-2 Barros-Barbosa, 2016, "Up-regulation of P2X7 receptor-mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex.", Epilepsia, 57, 99, 10.1111/epi.13263 Bartlett, 2017, "P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice.", PeerJ, 5, e3064, 10.7717/peerj.3064 Bauer, 2019, “Inflammation in psychiatric disorders: what comes first?”, Ann. N. Y. Acad. Sci., 1437, 57, 10.1111/nyas.13712 Beamer, 2016, “Purinergic mechanisms in neuroinflammation: an update from molecules to behavior.”, Neuropharmacology, 104, 94, 10.1016/j.neuropharm.2015.09.019 Beamer, 2017, “The ATP-Gated P2X7 receptor As a target for the treatment of drug-resistant epilepsy.”, Front. Neurosci., 11, 21, 10.3389/fnins.2017.00021 Beamer, 2019, “ATP release during seizures - A critical evaluation of the evidence.”, Brain Res. Bull., 151, 65, 10.1016/j.brainresbull.2018.12.021 Beamer, 2021, "Elevated blood purine levels as a biomarker of seizures and epilepsy.", Epilepsia, 10.1111/epi.16839 Bedner, 2015, "Astrocyte uncoupling as a cause of human temporal lobe epilepsy.", Brain, 138, 1208, 10.1093/brain/awv067 Bell, 2001, “Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury.”, Crit. Care Med., 29, 399, 10.1097/00003246-200102000-00033 Benarroch, 2008, "Adenosine and its receptors. Multiple modulatory functions and potential therapeutic targets for neurologic disease.", Neurology, 70, 231, 10.1212/01.wnl.0000297939.18236.ec Bennett, 2012, “Connexin and pannexin hemichannels in inflammatory responses of glia and neurons.”, Brain Res., 1487, 3, 10.1016/j.brainres.2012.08.042 Bergmann, 2019, “Generation and characterization of specific monoclonal antibodies and nanobodies directed against the ATP-Gated channel P2X4.”, Front. Cell. Neurosci., 13, 498, 10.3389/fncel.2019.00498 Berne, 1974, “Effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides.”, Circ. Res., 35, 262, 10.1161/01.RES.35.2.262 Bialer, 2012, "Why are antiepileptic drugs used for nonepileptic conditions?", Epilepsia, 53, 26, 10.1111/j.1528-1167.2012.03712.x Bialer, 2010, “Key factors in the discovery and development of new antiepileptic drugs.”, Nat. Rev. Drug Discov., 9, 68, 10.1038/nrd2997 Boison, 2008, “The adenosine kinase hypothesis of epileptogenesis.”, Prog. Neurobiol., 84, 249, 10.1016/j.pneurobio.2007.12.002 Boison, 2010, "Inhibitory RNA in epilepsy: research tools and therapeutic perspectives.", Epilepsia, 51, 1659, 10.1111/j.1528-1167.2010.02672.x Boison, 2011, “Methylxanthines, seizures, and excitotoxicity.”, Handb. Exp. Pharmacol., 251, 10.1007/978-3-642-13443-2_9 Boison, 2012, "Adenosine dysfunction in epilepsy.", Glia, 60, 1234, 10.1002/glia.22285 Boison, 2013, “Adenosine kinase: exploitation for therapeutic gain.”, Pharmacol. Rev., 65, 906, 10.1124/pr.112.006361 Boison, 2016, "Adenosinergic signaling in epilepsy.", Neuropharmacology, 104, 131, 10.1016/j.neuropharm.2015.08.046 Boison, 2015, “Comorbidities in Neurology: is adenosine the common link?”, Neuropharmacology, 97, 18, 10.1016/j.neuropharm.2015.04.031 Boison, 2019, “Epigenetics and epilepsy prevention: the therapeutic potential of adenosine and metabolic therapies.”, Neuropharmacology Boison, 2019, “Adenosine metabolism: emerging concepts for cancer therapy.”, Cancer Cell, 36, 582, 10.1016/j.ccell.2019.10.007 Boison, 2002, “Neonatal hepatic steatosis by disruption of the adenosine kinase gene.”, Proc. Natl. Acad. Sci. U. S. A., 99, 6985, 10.1073/pnas.092642899 Boison, 2010, “Adenosine signaling and function in glial cells.”, Cell Death Differ., 17, 1071, 10.1038/cdd.2009.131 Bonan, 2000, “Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy.”, Epilepsy Res., 39, 229, 10.1016/S0920-1211(00)00095-4 Borea, 2018, “Pharmacology of adenosine receptors: the state of the art.”, Physiol. Rev., 98, 1591, 10.1152/physrev.00049.2017 Bragatti, 2010, “Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews.”, Epileptic Disord., 12, 283 Burnstock, 2008, “Purinergic signalling and disorders of the central nervous system.”, Nat. Rev. Drug Discov., 7, 575, 10.1038/nrd2605 Burnstock, 2016, "An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.", Neuropharmacology, 104, 4, 10.1016/j.neuropharm.2015.05.031 Burnstock, 2016, “P2X ion channel receptors and inflammation.”, Purinergic Signal., 12, 59, 10.1007/s11302-015-9493-0 Campos, 2018, “In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.”, Epilepsy Res., 146, 63, 10.1016/j.eplepsyres.2018.07.008 Canas, 2018, “Neuronal adenosine A2A receptors are critical mediators of neurodegeneration triggered by convulsions.”, eNeuro, 5, 10.1523/ENEURO.0385-18.2018 Carrier, 2006, “Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.”, Proc. Natl. Acad. Sci. U. S. A., 103, 7895, 10.1073/pnas.0511232103 Cascella, 2009, “Schizophrenia and epilepsy: is there a shared susceptibility?”, Neurosci. Res., 63, 227, 10.1016/j.neures.2009.01.002 Cervenka, 2016, “The impact of the modified Atkins diet on lipid profiles in adults with epilepsy.”, Nutr. Neurosci., 19, 131, 10.1179/1476830514Y.0000000162 Chang, 2003, “Epilepsy.”, N. Engl. J. Med., 349, 1257, 10.1056/NEJMra022308 Chen, 2013, “Adenosine receptors as drug targets--what are the challenges?”, Nat. Rev. Drug Discov., 12, 265, 10.1038/nrd3955 Chen, 2018, “Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life.”, Neuropsychiatr. Dis. Treat., 14, 2389, 10.2147/NDT.S176047 Chitnis, 2017, “CNS inflammation and neurodegeneration.”, J. Clin. Invest., 127, 3577, 10.1172/JCI90609 Christian, 2020, “Sex differences in the epilepsies and associated comorbidities: implications for use and development of pharmacotherapies.”, Pharmacol. Rev., 72, 767, 10.1124/pr.119.017392 Chu, 2014, “Effect of ecto-5’-nucleotidase (eN) in astrocytes on adenosine and inosine formation.”, Purinergic Signal., 10, 603, 10.1007/s11302-014-9421-8 Chwalczuk, 2008, "[Influence of the antagonist of adenosine A1 receptors, 8-cyclopentyl-1, 3-dipropylxanthine, upon the anticonvulsant activity of antiepileptic drugs in mice].", Przegl Lek, 65, 759 Cieslak, 2017, “Role of the purinergic signaling in epilepsy.”, Pharmacol. Rep., 69, 130, 10.1016/j.pharep.2016.09.018 Ciruela, 2006, “Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.”, J. Neurosci., 26, 2080, 10.1523/JNEUROSCI.3574-05.2006 Clark, 1997, "Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans.", Neurosurgery, 41, 1284, 10.1097/00006123-199712000-00010 Craigie, 2013, “The relationship between P2X4 and P2X7: a physiologically important interaction?”, Front. Physiol., 4, 216, 10.3389/fphys.2013.00216 Crain, 2009, “Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia.”, J. Neuroinflammation, 6, 24, 10.1186/1742-2094-6-24 Cristovao-Ferreira, 2013, “A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.”, Purinergic Signal., 9, 433, 10.1007/s11302-013-9364-5 Cunha, 2016, “How does adenosine control neuronal dysfunction and neurodegeneration?”, J. Neurochem., 139, 1019, 10.1111/jnc.13724 Cunha, 1992, “Ecto-5’-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat.”, J. Neurochem., 59, 657, 10.1111/j.1471-4159.1992.tb09420.x Dale, 1998, “Delayed production of adenosine underlies temporal modulation of swimming in frog embryo.”, J. Physiol., 511, 265, 10.1111/j.1469-7793.1998.265bi.x Dale, 2002, “Resetting intrinsic purinergic modulation of neural activity: an associative mechanism?”, J. Neurosci., 22, 10461, 10.1523/JNEUROSCI.22-23-10461.2002 Dale, 2009, “Release of adenosine and ATP during ischemia and epilepsy.”, Curr. Neuropharmacol., 7, 160, 10.2174/157015909789152146 Dale, 2000, “Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice.”, J. Physiol., 526, 143, 10.1111/j.1469-7793.2000.00143.x Dale, 2019, “Point-of-care measurements reveal release of purines into venous blood of stroke patients.”, Purinergic Signal., 15, 237, 10.1007/s11302-019-09647-4 de Souza Neves, 2020, “Cardiometabolic risk and effectiveness of the modified Atkins Ketogenic Diet for adult patients with pharmacoresistant epilepsies in a middle-income country.”, Epilepsy Res., 160, 10.1016/j.eplepsyres.2020.106280 Devinsky, 2013, “Glia and epilepsy: excitability and inflammation.”, Trends Neurosci., 36, 174, 10.1016/j.tins.2012.11.008 Dhir, 2012, “Pentylenetetrazol (PTZ) kindling model of epilepsy.”, Curr. Protoc. Neurosci., 10.1002/0471142301.ns0937s58 Diamond, 2015, "Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development.", Epilepsia, 56, 1198, 10.1111/epi.13044 Diez, 2017, “Reducing extracellular Ca(2+) induces adenosine release via equilibrative nucleoside transporters to provide negative feedback control of activity in the Hippocampus.”, Front. Neural Circuits, 11, 75, 10.3389/fncir.2017.00075 Dogan, 2020, “The role of NMDA receptors in the effect of purinergic P2X7 receptor on spontaneous seizure activity in WAG/Rij rats with genetic absence epilepsy.”, Front. Neurosci., 14, 414, 10.3389/fnins.2020.00414 Dona, 2009, “Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine.”, Epilepsy Res., 83, 157, 10.1016/j.eplepsyres.2008.10.008 Dona, 2016, “Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsy.”, Purinergic Signal., 12, 295, 10.1007/s11302-016-9504-9 Dossi, 2018, “Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy.”, Sci. Transl. Med., 10, 10.1126/scitranslmed.aar3796 Dragunow, 1984, “Adenosine modulation of amygdala kindling.”, Exp. Neurol., 84, 654, 10.1016/0014-4886(84)90212-7 Dulla, 2009, “Intracellular acidification causes adenosine release during states of hyperexcitability in the hippocampus.”, J. Neurophysiol., 102, 1984, 10.1152/jn.90695.2008 Dunwiddie, 1980, “Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus.”, Br. J. Pharmacol., 69, 59, 10.1111/j.1476-5381.1980.tb10883.x Dunwiddie, 1997, “Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.”, J. Neurosci., 17, 607, 10.1523/JNEUROSCI.17-02-00607.1997 During, 1992, “Adenosine: a potential mediator of seizure arrest and postictal refractoriness.”, Ann. Neurol., 32, 618, 10.1002/ana.410320504 El Yacoubi, 2001, “Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.”, Br. J. Pharmacol., 134, 68, 10.1038/sj.bjp.0704240 El Yacoubi, 2008, "Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.", Neuropharmacology, 55, 35, 10.1016/j.neuropharm.2008.04.007 El Yacoubi, 2009, “Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.”, Naunyn Schmiedebergs Arch. Pharmacol., 380, 223, 10.1007/s00210-009-0426-8 Engel, 1996, “Introduction to temporal lobe epilepsy.”, Epilepsy Res., 26, 141, 10.1016/S0920-1211(96)00043-5 Engel, 2012, “Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.”, FASEB J., 26, 1616, 10.1096/fj.11-196089 Engel, 2016, "ATPergic signalling during seizures and epilepsy.", Neuropharmacology, 104, 140, 10.1016/j.neuropharm.2015.11.001 Engel, 2017, “A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22.”, Biochim. Biophys. Acta Mol Cell Res., 1864, 255, 10.1016/j.bbamcr.2016.11.007 Etherington, 2004, “Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner.”, Eur. J. Neurosci., 19, 2539, 10.1111/j.0953-816X.2004.03355.x Evans, 1982, “Adenosine receptors mediating cardiac depression.”, Life Sci., 31, 2425, 10.1016/0024-3205(82)90746-9 Eyo, 2014, “Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus.”, J. Neurosci., 34, 10528, 10.1523/JNEUROSCI.0416-14.2014 Faingold, 2016, “Susceptibility to seizure-induced sudden death in DBA/2 mice is altered by adenosine.”, Epilepsy Res., 124, 49, 10.1016/j.eplepsyres.2016.05.007 Fedele, 2005, "Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation.", Brain, 128, 2383, 10.1093/brain/awh555 Fedele, 2006, “Adenosine A1 receptors are crucial in keeping an epileptic focus localized.”, Exp. Neurol., 200, 184, 10.1016/j.expneurol.2006.02.133 Feinstein, 1970, “The pre-therapeutic classification of Co-morbidity in chronic disease.”, J. Chronic Dis., 23, 455, 10.1016/0021-9681(70)90054-8 Fischer, 2016, “Critical evaluation of P2X7 receptor antagonists in selected seizure models.”, PLoS One, 11, 10.1371/journal.pone.0156468 Fisher, 2000, “The postictal state: a neglected entity in the management of epilepsy.”, Epilepsy Behav., 1, 52, 10.1006/ebeh.2000.0023 Franke, 2004, "P2Y receptor expression on astrocytes in the nucleus accumbens of rats.", Neuroscience, 127, 431, 10.1016/j.neuroscience.2004.05.003 Fredholm, 1997, “Adenosine and neuroprotection.”, Int. Rev. Neurobiol., 40, 259, 10.1016/S0074-7742(08)60723-0 Fredholm, 2014, “Adenosine--a physiological or pathophysiological agent?”, J. Mol. Med., 92, 201, 10.1007/s00109-013-1101-6 Fredholm, 2011, “International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.”, Pharmacol. Rev., 63, 1, 10.1124/pr.110.003285 Freeman, 2009, "A blinded, crossover study of the efficacy of the ketogenic diet.", Epilepsia, 50, 322, 10.1111/j.1528-1167.2008.01740.x Frenguelli, 2007, “Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus.”, J. Neurochem., 101, 1400, 10.1111/j.1471-4159.2006.04425.x Fukuda, 2010, "Adenosine A1 receptor blockage mediates theophylline-associated seizures.", Epilepsia, 51, 483, 10.1111/j.1528-1167.2009.02382.x Ganesana, 2018, "Early changes in transient adenosine during cerebral ischemia and reperfusion injury.", PLoS One, 13, 10.1371/journal.pone.0196932 Gebril, 2020, “Adenosine kinase inhibition promotes proliferation of neural stem cells after traumatic brain injury.”, Brain Commun., 10.1093/braincomms/fcaa017 Gessi, 2011, “Adenosine receptor targeting in health and disease.”, Expert Opin. Investig. Drugs, 20, 1591, 10.1517/13543784.2011.627853 Gouder, 2003, "Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy.", Epilepsia, 44, 877, 10.1046/j.1528-1157.2003.03603.x Gouder, 2004, “Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis.”, J. Neurosci., 24, 692, 10.1523/JNEUROSCI.4781-03.2004 Grabenstatter, 2007, "Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.", Epilepsia, 48, 2287 Griffith, 1996, “Nucleoside and nucleobase transport systems of mammalian cells.”, Biochim. Biophys. Acta, 1286, 153, 10.1016/S0304-4157(96)00008-1 Gundlfinger, 2007, “Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels.”, J. Physiol., 582, 263, 10.1113/jphysiol.2007.132613 Guttinger, 2005, “Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.”, Exp. Neurol., 193, 53, 10.1016/j.expneurol.2004.12.012 Guzman, 2016, “P2Y receptors in synaptic transmission and plasticity: therapeutic potential in cognitive dysfunction.”, Neural Plast., 2016, 10.1155/2016/1207393 Hamann, 1996, “Non-synaptic release of ATP by electrical stimulation in slices of rat hippocampus, cerebellum and habenula.”, Eur. J. Neurosci., 8, 1510, 10.1111/j.1460-9568.1996.tb01613.x Hargus, 2012, "Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A(1)-receptor activation.", Epilepsia, 53, 168, 10.1111/j.1528-1167.2011.03337.x Heinrich, 2012, “K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study.”, Br. J. Pharmacol., 167, 1003, 10.1111/j.1476-5381.2012.01932.x Henshall, 2015, “P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus.”, Epilepsy Behav., 49, 8, 10.1016/j.yebeh.2015.02.031 Henshall, 2015, “Epigenetics and Epilepsy.”, Cold Spring Harb. Perspect. Med., 5 Herlenius, 1997, “Adenosine modulates inspiratory neurons and the respiratory pattern in the brainstem of neonatal rats.”, Pediatr. Res., 42, 46, 10.1203/00006450-199707000-00008 Hesdorffer, 2013, "Sudden unexpected death in epilepsy. Potential role of antiepileptic drugs.", CNS Drugs, 27, 113, 10.1007/s40263-012-0006-1 Hirsch, 2010, “Is sudden unexpected death in epilepsy due to postictal brain shutdown?”, Ann. Neurol., 68, 773, 10.1002/ana.22242 Huang, 2017, “Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat Hippocampus.”, J. Mol. Neurosci., 63, 173, 10.1007/s12031-017-0968-z Huber, 2001, “Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy.”, Proc. Natl. Acad. Sci. U. S. A., 98, 7611, 10.1073/pnas.131102898 Huizinga, 2012, “Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.”, J. Neuroinflammation, 9, 266, 10.1186/1742-2094-9-266 Hyde, 2001, “The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.”, Mol. Membr. Biol., 18, 53, 10.1080/09687680118799 Ilie, 2012, “Adenosine release during seizures attenuates GABAA receptor-mediated depolarization.”, J. Neurosci., 32, 5321, 10.1523/JNEUROSCI.5412-11.2012 Illes, 2017, “Neuronal P2X7 receptors revisited: do they really exist?”, J. Neurosci., 37, 7049, 10.1523/JNEUROSCI.3103-16.2017 Illes, 2019, “Astroglia-Derived ATP modulates CNS neuronal circuits.”, Trends Neurosci., 42, 885, 10.1016/j.tins.2019.09.006 Illes, 2019, “Pathological ATPergic signaling in major depression and bipolar disorder.”, Front. Mol. Neurosci., 12, 331, 10.3389/fnmol.2019.00331 Imura, 2013, "Microglia release ATP by exocytosis.", Glia, 61, 1320, 10.1002/glia.22517 Inoue, 2017, “Molecular basis of nucleobase transport systems in mammals.”, Biol. Pharm. Bull., 40, 1130, 10.1248/bpb.b17-00374 Jacobson, 2010, “P2Y nucleotide receptors: promise of therapeutic applications.”, Drug Discov. Today, 15, 570, 10.1016/j.drudis.2010.05.011 Jacobson, 1996, “Adenosine receptor ligands: differences with acute versus chronic treatment.”, Trends Pharmacol. Sci., 17, 108, 10.1016/0165-6147(96)10002-X James, 2002, “Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology.”, J. Nutr., 132, 2361S, 10.1093/jn/132.8.2361S Jansen, 2019, “Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of the localization of the epilepsy.”, Epilepsy Behav., 94, 288, 10.1016/j.yebeh.2018.06.046 Jennings, 2001, "Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.", Neuropharmacology, 40, 722, 10.1016/S0028-3908(00)00207-0 Jimenez-Mateos, 2015, “microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus.”, Sci. Rep., 5, 17486, 10.1038/srep17486 Jimenez-Mateos, 2019, “Regulation of P2X7 receptor expression and function in the brain.”, Brain Res. Bull., 151, 153, 10.1016/j.brainresbull.2018.12.008 Jimenez-Pacheco, 2013, "Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079.", Epilepsia, 54, 1551, 10.1111/epi.12257 Jimenez-Pacheco, 2016, “Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and Gliosis in experimental temporal lobe epilepsy.”, J. Neurosci., 36, 5920, 10.1523/JNEUROSCI.4009-15.2016 Jo, 1999, “Synaptic corelease of ATP and GABA in cultured spinal neurons.”, Nat. Neurosci., 2, 241, 10.1038/6344 Kaczmarek-Hajek, 2018, "Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody.", Elife, 7, 10.7554/eLife.36217 Kang, 2003, “P2X2 and P2X4 receptor expression is regulated by a GABA(A) receptor-mediated mechanism in the gerbil hippocampus.”, Brain Res. Mol. Brain Res., 116, 168, 10.1016/S0169-328X(03)00260-2 Kanner, 2012, “Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders?”, Lancet Neurol., 11, 1093, 10.1016/S1474-4422(12)70201-6 Kanner, 2018, “Bidirectional relations among common psychiatric and neurologic comorbidities and epilepsy: do they have an impact on the course of the seizure disorder?”, Epilepsia Open, 3, 210, 10.1002/epi4.12278 Kawamura, 2010, “Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.”, J. Neurosci., 30, 3886, 10.1523/JNEUROSCI.0055-10.2010 Keezer, 2016, “Comorbidities of epilepsy: current concepts and future perspectives.”, Lancet Neurol., 15, 106, 10.1016/S1474-4422(15)00225-2 Khakh, 2006, "P2X receptors as cell-surface ATP sensors in health and disease.", Nature, 442, 527, 10.1038/nature04886 Khan, 2019, “Astrocytic rather than neuronal P2X7 receptors modulate the function of the tri-synaptic network in the rodent hippocampus.”, Brain Res. Bull., 151, 164, 10.1016/j.brainresbull.2018.07.016 Kiese, 2016, “Dynamic regulation of the adenosine kinase gene during early postnatal brain development and maturation.”, Front. Mol. Neurosci., 9, 99, 10.3389/fnmol.2016.00099 Kim, 2011, “The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice.”, J. Clin. Invest., 121, 2037, 10.1172/JCI44818 Kim, 2009, “Blockade of P2X receptor prevents astroglial death in the dentate gyrus following pilocarpine-induced status epilepticus.”, Neurol. Res., 31, 982, 10.1179/174313209X389811 Kim, 2010, “P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus.”, J. Neuroinflammation, 7, 65, 10.1186/1742-2094-7-65 Kim, 2011, “P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-alpha-mediated pathway in the rat hippocampus following status epilepticus.”, J. Neuroinflammation, 8, 62, 10.1186/1742-2094-8-62 Kiryu-Seo, 2008, “Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons.”, J. Biol. Chem., 283, 6988, 10.1074/jbc.M707514200 Klaft, 2016, "Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices.", Epilepsia, 57, 746, 10.1111/epi.13360 Klein, 2015, "Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.", Neuropharmacology, 90, 53, 10.1016/j.neuropharm.2014.11.008 Klein, 2018, “Commonalities in epileptogenic processes from different acute brain insults: do they translate?”, Epilepsia, 59, 37, 10.1111/epi.13965 Klyuch, 2012, “Deletion of ecto-5’-nucleotidase (CD73) reveals direct action potential-dependent adenosine release.”, J. Neurosci., 32, 3842, 10.1523/JNEUROSCI.6052-11.2012 Knutsen, 1997, Adenosine and ATP in epilepsy, 432 Kobow, 2011, "The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?", Epilepsia, 52, 15, 10.1111/j.1528-1167.2011.03145.x Kobow, 2009, “Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy.”, J. Neuropathol. Exp. Neurol., 68, 356, 10.1097/NEN.0b013e31819ba737 Kobow, 2013, “Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.”, Acta Neuropathol., 126, 741, 10.1007/s00401-013-1168-8 Kochanek, 1997, “The role of adenosine during the period of delayed cerebral swelling after severe traumatic brain injury in humans.”, Acta Neurochir. Suppl., 70, 109 Kochanek, 2006, “Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury.”, J. Cereb. Blood Flow Metab., 26, 565, 10.1038/sj.jcbfm.9600218 Kong, 2004, “Mammalian nucleoside transporters.”, Curr. Drug Metab., 5, 63, 10.2174/1389200043489162 Kopp, 2019, “P2X7 interactions and signaling - making head or tail of it.”, Front. Mol. Neurosci., 12, 183, 10.3389/fnmol.2019.00183 Kossoff, 2009, "Ketogenic diets: evidence for short- and long-term efficacy.", Neurotherapeutics, 6, 406, 10.1016/j.nurt.2009.01.005 Koszalka, 2004, “Targeted disruption of cd73/ecto-5’-nucleotidase alters thromboregulation and augments vascular inflammatory response.”, Circ. Res., 95, 814, 10.1161/01.RES.0000144796.82787.6f Kovacs, 2013, “Uridine modulates neuronal activity and inhibits spike-wave discharges of absence epileptic Long Evans and Wistar Albino Glaxo/Rijswijk rats.”, Brain Res. Bull., 97, 16, 10.1016/j.brainresbull.2013.05.009 Kredich, 1977, "Role of S-adenosylhomocysteine in adenosinemediated toxicity in cultured mouse T lymphoma cells.", Cell, 12, 931, 10.1016/0092-8674(77)90157-X Kull, 2000, “Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum.”, Mol. Pharmacol., 58, 771, 10.1124/mol.58.4.771 Lado, 2008, "How do seizures stop?", Epilepsia, 49, 1651, 10.1111/j.1528-1167.2008.01669.x LaFrance, 2008, “Psychiatric comorbidities in epilepsy.”, Int. Rev. Neurobiol., 83, 347, 10.1016/S0074-7742(08)00020-2 Lalo, 2014, “Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex.”, PLoS Biol., 12, 10.1371/journal.pbio.1001747 Lam, 2017, “Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer’s disease.”, Nat. Med., 23, 678, 10.1038/nm.4330 Langer, 2008, “Distribution of ectonucleotidases in the rodent brain revisited.”, Cell Tissue Res., 334, 199, 10.1007/s00441-008-0681-x Lanser, 2017, "Disruption of the ATP/adenosine balance in CD39(-/-) mice is associated with handling-induced seizures.", Immunology, 152, 589, 10.1111/imm.12798 Lee, 2008, "GFAP promoter elements required for region-specific and astrocyte-specific expression.", Glia, 56, 481, 10.1002/glia.20622 Li, 2019, “Comparison of kainate-induced seizures, cognitive impairment and hippocampal damage in male and female mice.”, Life Sci., 232, 10.1016/j.lfs.2019.116621 Li, 2007, “Adenosine dysfunction in astrogliosis: cause for seizure generation?”, Neuron Glia Biol., 3, 353, 10.1017/S1740925X0800015X Li, 2007, "Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants.", Brain, 130, 1276, 10.1093/brain/awm057 Li, 2008, “Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice.”, J. Clin. Invest., 118, 571 Li, 2009, “Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.”, Epilepsy Res., 84, 238, 10.1016/j.eplepsyres.2009.01.002 Li, 2012, "Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?", Glia, 60, 83, 10.1002/glia.21250 Li, 2013, "Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures.", PLoS One, 8, 10.1371/journal.pone.0067060 Li, 2011, "[Sedative, hypnotic and anticonvulsive effects of an adenosine analogue WS090501].", Yao Xue Xue Bao, 46, 742 Lie, 1999, “5’-Nucleotidase activity indicates sites of synaptic plasticity and reactive synaptogenesis in the human brain.”, J. Neuropathol. Exp. Neurol., 58, 451, 10.1097/00005072-199905000-00004 Lietsche, 2016, “Extracellular levels of ATP and acetylcholine during lithium-pilocarpine induced status epilepticus in rats.”, Neurosci. Lett., 611, 69, 10.1016/j.neulet.2015.11.028 Lin, 2012, "Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.", Lancet, 380, 1180, 10.1016/S0140-6736(12)61455-X Lopatar, 2011, “Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: evidence from purine biosensors and P2 receptor agonists and antagonists.”, Neuropharmacology, 61, 25, 10.1016/j.neuropharm.2011.02.011 Lopes, 2002, "Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.", Neuroscience, 112, 319, 10.1016/S0306-4522(02)00080-5 Loscher, 2017, “Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs.”, Neurochem. Res., 42, 1873, 10.1007/s11064-017-2222-z Loscher, 2020, “The holy grail of epilepsy prevention: preclinical approaches to antiepileptogenic treatments.”, Neuropharmacology, 167, 10.1016/j.neuropharm.2019.04.011 Lovatt, 2012, “Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.”, Proc. Natl. Acad. Sci. U. S. A., 109, 6265, 10.1073/pnas.1120997109 Lusardi, 2012, “Caffeine prevents acute mortality after TBI in rats without increased morbidity.”, Exp. Neurol., 234, 161, 10.1016/j.expneurol.2011.12.026 Lusardi, 2015, "Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.", Neuropharmacology, 99, 500, 10.1016/j.neuropharm.2015.08.007 Marchi, 2002, “Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.”, Br. J. Pharmacol., 136, 434, 10.1038/sj.bjp.0704712 Mares, 2010, “Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors.”, J. Neural Transm. (Vienna), 117, 1269, 10.1007/s00702-010-0465-9 Maroso, 2010, “Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.”, Nat. Med., 16, 413, 10.1038/nm.2127 Martin-McGill, 2018, “Ketogenic diets for drug-resistant epilepsy.”, Cochrane Database Syst. Rev., 11 Masino, 2008, “Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?”, Trends Neurosci., 31, 273, 10.1016/j.tins.2008.02.009 Masino, 2009, "The ketogenic diet and epilepsy: is adenosine the missing link?", Epilepsia, 50, 332, 10.1111/j.1528-1167.2008.01771.x Masino, 2011, “A ketogenic diet suppresses seizures in mice through adenosine A(1) receptors.”, J. Clin. Invest., 121, 2679, 10.1172/JCI57813 Masino, 2012, “Purines and neuronal excitability: links to the ketogenic diet.”, Epilepsy Res., 100, 229, 10.1016/j.eplepsyres.2011.07.014 Masse, 2012, “Purines as potential morphogens during embryonic development.”, Purinergic Signal., 8, 503, 10.1007/s11302-012-9290-y Masse, 2010, “Ectophosphodiesterase/nucleotide phosphohydrolase (Enpp) nucleotidases: cloning, conservation and developmental restriction.”, Int. J. Dev. Biol., 54, 181, 10.1387/ijdb.092879km McGaraughty, 2005, “Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.”, Curr. Top. Med. Chem., 5, 43, 10.2174/1568026053386845 Melani, 2005, “ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.”, Neurochem. Int., 47, 442, 10.1016/j.neuint.2005.05.014 Menendez Mendez, 2020, “Neonatal seizures and purinergic signalling.”, Int. J. Mol. Sci., 21, 10.3390/ijms21217832 Mesuret, 2014, “P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage.”, CNS Neurosci. Ther., 20, 556, 10.1111/cns.12272 Milior, 2020, “Distinct P2Y receptors mediate extension and retraction of microglial processes in epileptic and peri-tumoral human tissue.”, J. Neurosci., 10.1523/JNEUROSCI.0218-19.2019 Miller-Delaney, 2015, "Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy.", Brain, 138, 616, 10.1093/brain/awu373 Miras-Portugal, 2017, “Neuronal P2X7 receptor: involvement in neuronal physiology and pathology.”, J. Neurosci., 37, 7063, 10.1523/JNEUROSCI.3104-16.2017 Miras-Portugal, 2019, “P2 receptor interaction and signalling cascades in neuroprotection.”, Brain Res. Bull., 151, 74, 10.1016/j.brainresbull.2018.12.012 Mo, 2019, “Microglial P2Y12 receptor regulates seizure-induced neurogenesis and immature neuronal projections.”, J. Neurosci., 39, 9453, 10.1523/JNEUROSCI.0487-19.2019 Monif, 2009, “The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore.”, J. Neurosci., 29, 3781, 10.1523/JNEUROSCI.5512-08.2009 Morgan, 2020, “Characterization of the expression of the ATP-Gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse.”, Neurosci. Bull., 10.1007/s12264-020-00573-9 Moshe, 2015, "Epilepsy: new advances.", Lancet, 385, 884, 10.1016/S0140-6736(14)60456-6 Muzzi, 2013, “Anticonvulsant effect of AMP by direct activation of adenosine A1 receptor.”, Exp. Neurol., 250, 189, 10.1016/j.expneurol.2013.09.010 Nieoczym, 2017, “Evaluation of the anticonvulsant effect of brilliant blue g, a selective P2X7 receptor antagonist, in the iv PTZ-, maximal electroshock-, and 6 hz-induced seizure tests in mice.”, Neurochem. Res., 42, 3114, 10.1007/s11064-017-2348-z Nikolic, 2018, "Blocking TNFalpha-driven astrocyte purinergic signaling restores normal synaptic activity during epileptogenesis.", Glia, 66, 2673, 10.1002/glia.23519 Orellana, 2011, “ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels.”, J. Neurochem., 118, 826, 10.1111/j.1471-4159.2011.07210.x Pankratov, 2009, "P2X receptors and synaptic plasticity.", Neuroscience, 158, 137, 10.1016/j.neuroscience.2008.03.076 Patel, 2017, “Psychiatric comorbidities and outcomes in epilepsy patients: an insight from a nationwide inpatient analysis in the United States.”, Cureus, 9, e1686 Peleli, 2017, “Pharmacological targeting of adenosine receptor signaling.”, Mol. Aspects Med., 55, 4, 10.1016/j.mam.2016.12.002 Picher, 2004, “Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis.”, J. Biol. Chem., 279, 20234, 10.1074/jbc.M400305200 Pitkanen, 2014, "Past and present definitions of epileptogenesis and its biomarkers.", Neurotherapeutics, 11, 231, 10.1007/s13311-014-0257-2 Pitkanen, 2009, "From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options.", Epilepsia, 50, 21, 10.1111/j.1528-1167.2008.02007.x Pitkanen, 2015, “Epileptogenesis.”, Cold Spring Harb. Perspect. Med., 5, 10.1101/cshperspect.a022822 Plesner, 1995, “Ecto-ATPases: identities and functions.”, Int. Rev. Cytol., 158, 141, 10.1016/S0074-7696(08)62487-0 Rappold, 2006, “P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain.”, Brain Res., 1089, 171, 10.1016/j.brainres.2006.03.040 Rassendren, 2016, “Purinergic signaling in epilepsy.”, J. Neurosci. Res., 94, 781, 10.1002/jnr.23770 Rebola, 2005, "Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex.", Epilepsia, 46, 159, 10.1111/j.1528-1167.2005.01026.x Rebola, 2008, "Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses.", Neuron, 57, 121, 10.1016/j.neuron.2007.11.023 Rebola, 2011, “Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.”, J. Neurochem., 117, 100, 10.1111/j.1471-4159.2011.07178.x Reklow, 2019, “The purinome and the preBotzinger complex - a menage of unexplored mechanisms that may Modulate/Shape the hypoxic ventilatory response.”, Front. Cell. Neurosci., 13, 365, 10.3389/fncel.2019.00365 Ren, 2007, “Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.”, Exp. Neurol., 208, 26, 10.1016/j.expneurol.2007.07.016 Robel, 2015, “Reactive astrogliosis causes the development of spontaneous seizures.”, J. Neurosci., 35, 3330, 10.1523/JNEUROSCI.1574-14.2015 Robertson, 2001, “Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity.”, Crit. Care Med., 29, 2287, 10.1097/00003246-200112000-00009 Robson, 2006, “The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance.”, Purinergic Signal., 2, 409, 10.1007/s11302-006-9003-5 Rodrigues, 2016, “Psychogenic non-epileptic seizures in early Huntington’s disease.”, Pract. Neurol., 16, 452, 10.1136/practneurol-2016-001423 Rodriguez-Alvarez, 2017, "Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice.", Neuropharmacology, 116, 351, 10.1016/j.neuropharm.2017.01.005 Roseti, 2008, “Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors.”, Proc. Natl. Acad. Sci. U. S. A., 105, 15118, 10.1073/pnas.0807277105 Rozmer, 2017, “Pilocarpine-Induced status epilepticus increases the sensitivity of P2X7 and P2Y1 receptors to nucleotides at neural progenitor cells of the juvenile rodent Hippocampus.”, Cereb. Cortex, 27, 3568 Ruigrok, 2014, “A meta-analysis of sex differences in human brain structure.”, Neurosci. Biobehav. Rev., 39, 34, 10.1016/j.neubiorev.2013.12.004 Sandau, 2019, "Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.", Epilepsia, 60, 615, 10.1111/epi.14674 Sawynok, 2016, "Adenosine receptor targets for pain.", Neuroscience, 338, 1, 10.1016/j.neuroscience.2015.10.031 Scheffer, 2017, “ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology.”, Epilepsia, 58, 512, 10.1111/epi.13709 Schetinger, 2007, "NTPDase and 5’-nucleotidase activities in physiological and disease conditions: new perspectives for human health.", Biofactors, 31, 77, 10.1002/biof.5520310205 Schwarz, 2012, “Sex, glia, and development: interactions in health and disease.”, Horm. Behav., 62, 243, 10.1016/j.yhbeh.2012.02.018 Schwiebert, 2003, “Extracellular ATP as a signaling molecule for epithelial cells.”, Biochim. Biophys. Acta, 1615, 7, 10.1016/S0005-2736(03)00210-4 Sebastian-Serrano, 2015, Tissue-nonspecific alkaline phosphatase regulates purinergic transmission in the central nervous system during development and disease, Comput. Struct. Biotechnol. J., 13, 95, 10.1016/j.csbj.2014.12.004 Sebastian-Serrano, 2016, Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation, Hum. Mol. Genet., 25, 4143, 10.1093/hmg/ddw248 Seminario-Vidal, 2009, Assessment of extracellular ATP concentrations, Methods Mol. Biol., 574, 25, 10.1007/978-1-60327-321-3_3 Shen, 2010, A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance, Epilepsia, 51, 465, 10.1111/j.1528-1167.2009.02248.x Shen, 2012, Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia, J. Clin. Invest., 122, 2567, 10.1172/JCI62378 Simoes, 2018, Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation, Cell Death Dis., 9, 297, 10.1038/s41419-018-0351-1 Sims, 2014, Activity-dependent adenosine release may be linked to activation of Na(+)-K(+) ATPase: an in vitro rat study, PLoS One, 9, 10.1371/journal.pone.0087481 Sirven, 2015, Epilepsy: a Spectrum disorder, Cold Spring Harb. Perspect. Med., 5, 10.1101/cshperspect.a022848 Solle, 2001, Altered cytokine production in mice lacking P2X(7) receptors, J. Biol. Chem., 276, 125, 10.1074/jbc.M006781200 Soni, 2015, Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats, Epilepsy Behav., 48, 4, 10.1016/j.yebeh.2015.04.056 Sperlagh, 2014, P2X7 receptor: an emerging target in central nervous system diseases, Trends Pharmacol. Sci., 35, 537, 10.1016/j.tips.2014.08.002 Sperlagh, 2002, Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus, J. Neurochem., 81, 1196, 10.1046/j.1471-4159.2002.00920.x Sperlagh, 2006, P2X7 receptors in the nervous system, Prog. Neurobiol., 78, 327, 10.1016/j.pneurobio.2006.03.007 Stafstrom, 2012, The ketogenic diet as a treatment paradigm for diverse neurological disorders, Front. Pharmacol., 3, 59, 10.3389/fphar.2012.00059 Stenberg, 2003, Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor, J. Sleep Res., 12, 283, 10.1046/j.0962-1105.2003.00367.x Stockwell, 2017, Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration, Molecules, 22, 10.3390/molecules22040676 Strater, 2006, Ecto-5’-nucleotidase: structure function relationships, Purinergic Signal., 2, 343, 10.1007/s11302-006-9000-8 Studer, 2006, Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme, Neuroscience, 142, 125, 10.1016/j.neuroscience.2006.06.016 Suadicani, 2006, P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling, J. Neurosci., 26, 1378, 10.1523/JNEUROSCI.3902-05.2006 Sukigara, 2014, Expression of astrocyte-related receptors in cortical dysplasia with intractable epilepsy, J. Neuropathol. Exp. Neurol., 73, 798, 10.1097/NEN.0000000000000099 Sun, 2018, A purinergic P2 receptor family-mediated increase in Thrombospondin-1 bolsters synaptic density and epileptic seizure activity in the amygdala-kindling rat model, Front. Cell. Neurosci., 12, 302, 10.3389/fncel.2018.00302 Szybala, 2009, Antiepileptic effects of silk-polymer based adenosine release in kindled rats, Exp. Neurol., 219, 126, 10.1016/j.expneurol.2009.05.018 Tao, 2010, SUDEP, suspected positional airway obstruction, and hypoventilation in postictal coma, Epilepsia, 51, 2344, 10.1111/j.1528-1167.2010.02719.x Taylor, 2011, Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review, Epilepsia, 52, 2168, 10.1111/j.1528-1167.2011.03213.x Theofilas, 2011, Adenosine kinase as a target for therapeutic antisense strategies in epilepsy, Epilepsia, 52, 589, 10.1111/j.1528-1167.2010.02947.x Thijs, 2019, Epilepsy in adults, Lancet, 393, 689, 10.1016/S0140-6736(18)32596-0 Timmers, 2018, Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants, J. Psychopharmacol., 32, 1341, 10.1177/0269881118800067 Tosh, 2012, Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity, J. Med. Chem., 55, 8075, 10.1021/jm300965a Ugarkar, 2000, Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues, J. Med. Chem., 43, 2883, 10.1021/jm000024g Ulmann, 2013, Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus, Glia, 61, 1306, 10.1002/glia.22516 Van Gompel, 2014, "Increased cortical extracellular adenosine correlates with seizure termination.", Epilepsia, 55, 233, 10.1111/epi.12511 Vandam, 2008, “Rhythm generation by the pre-Botzinger complex in medullary slice and island preparations: effects of adenosine A(1) receptor activation.”, BMC Neurosci., 9, 95, 10.1186/1471-2202-9-95 Velioglu, 2005, "The impact of migraine on epilepsy: a prospective prognosis study.", Cephalalgia, 25, 528, 10.1111/j.1468-2982.2005.00912.x Vezzani, 2007, “New roles for interleukin-1 Beta in the mechanisms of epilepsy.”, Epilepsy Curr., 7, 45, 10.1111/j.1535-7511.2007.00165.x Vezzani, 2019, “Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy.”, Nat. Rev. Neurol., 15, 459, 10.1038/s41582-019-0217-x Vianna, 2002, "Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies.", Epilepsia, 43, 227, 10.1046/j.1528-1157.43.s.5.26.x Vianna, 2005, "Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.", Epilepsia, 46, 166, 10.1111/j.1528-1167.2005.01027.x von Kugelgen, 2019, “Pharmacology of P2Y receptors.”, Brain Res. Bull., 151, 12, 10.1016/j.brainresbull.2019.03.010 von Kugelgen, 2016, "Pharmacology and structure of P2Y receptors.", Neuropharmacology, 104, 50, 10.1016/j.neuropharm.2015.10.030 Von Lubitz, 1994, “Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.”, Eur. J. Pharmacol., 253, 95, 10.1016/0014-2999(94)90762-5 Vossel, 2016, “Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease.”, Ann. Neurol., 80, 858, 10.1002/ana.24794 Vossel, 2017, “Epileptic activity in Alzheimer’s disease: causes and clinical relevance.”, Lancet Neurol., 16, 311, 10.1016/S1474-4422(17)30044-3 Wall, 2008, “Activity-dependent release of adenosine: a critical re-evaluation of mechanism.”, Curr. Neuropharmacol., 6, 329, 10.2174/157015908787386087 Wall, 2013, “Neuronal transporter and astrocytic ATP exocytosis underlie activity-dependent adenosine release in the hippocampus.”, J. Physiol., 591, 3853, 10.1113/jphysiol.2013.253450 Wall, 2007, “Control of basal extracellular adenosine concentration in rat cerebellum.”, J. Physiol., 582, 137, 10.1113/jphysiol.2007.132050 Wellmann, 2018, “Astroglial Ca(2+)-Dependent hyperexcitability requires P2Y1 purinergic receptors and Pannexin-1 channel activation in a chronic model of epilepsy.”, Front. Cell. Neurosci., 12, 446, 10.3389/fncel.2018.00446 Wieraszko, 1989, “Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice.”, Neurosci. Lett., 106, 287, 10.1016/0304-3940(89)90178-X Wiesner, 1999, “Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.”, J. Pharmacol. Exp. Ther., 289, 1669 Williams-Karnesky, 2013, “Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.”, J. Clin. Invest., 123, 3552, 10.1172/JCI65636 Wu, 1978, “Distribution and release of adenosine triphosphate in rat brain.”, Neurochem. Res., 3, 563, 10.1007/BF00963759 Wu, 1994, "Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus.", Neuron, 12, 1139, 10.1016/0896-6273(94)90321-2 Xia, 2012, “Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors.”, J. Physiol., 590, 2285, 10.1113/jphysiol.2012.227983 Xia, 2018, “Modulation of P2X purinoceptor 3 (P2X3) in pentylenetetrazole-induced kindling epilepsy in rats.”, Med. Sci. Monit., 24, 6165, 10.12659/MSM.910352 Yee, 2007, “Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs.”, Eur. J. Neurosci., 26, 3237, 10.1111/j.1460-9568.2007.05897.x Yegutkin, 2006, “The detection of micromolar pericellular ATP pool on lymphocyte surface by using lymphoid ecto-adenylate kinase as intrinsic ATP sensor.”, Mol. Biol. Cell, 17, 3378, 10.1091/mbc.e05-10-0993 Yoon, 1991, “Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus.”, J. Neurosci., 11, 1375, 10.1523/JNEUROSCI.11-05-01375.1991 Zhou, 2016, “Upregulated P2X3 receptor expression in patients with intractable temporal lobe epilepsy and in a rat model of epilepsy.”, Neurochem. Res., 41, 1263, 10.1007/s11064-015-1820-x Zhu, 2012, “Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy.”, J. Mol. Neurosci., 46, 420, 10.1007/s12031-011-9602-7 Zimmermann, 2000, “Extracellular metabolism of ATP and other nucleotides.”, Naunyn Schmiedebergs Arch. Pharmacol., 362, 299, 10.1007/s002100000309